Arteriorcyte, a developer of stem cell products and medical devices in Cleveland, has launched
Compass Biomedical to speed up the delivery to patients three Arteriocyte stem cells products. Created in December 2012, Compass officially got underway in June.
“The purpose of Compass is to help solve the issues in getting stem cells to patients,” says Kolby Day, Compass Biomedical vice president and general manager of research and development. “The challenges are having enough stem cells and improving the tools used.”
Compass supplies three product lines used to grow stem cells for research and in clinical settings. The products mimic bone marrow and promote the growth of stem cell cultures. “Arteriocyte is more the research and development company, while Compass is more of the team that sells, markets and gets those products into the hands of people who can use them,” says Day.
Compass has hired four people since December. As Arteriocyte develops new products, Day expects Compass will in turn expand its team. “We want to continue to build the sales team and continue finding products to sell,” he says. “We anticipate bringing in at least two to three products in the next six months, and we will be hiring based on demand.”
Source: Kolby Day
Writer: Karin Connelly